Among the amplification driver genes, NRAS (in breast carcinoma and skin melanoma), ERBB2 (in gastric carcinoma, esophageal carcinoma), and NFATC2 (in ovarian carcinoma and pancreatic carcinoma) were identified in more than one cancer type. Here, NRAS is linked to cutaneous melanoma.